Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 11Active not recruiting 7Withdrawn 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Breast Neoplasms 83Neoplasms 57Prostatic Neoplasms 41Colorectal Neoplasms 41Carcinoma, Non-Small-Cell Lung 33Lung Neoplasms 29Multiple Myeloma 24Leukemia, Myeloid, Acute 22Head and Neck Neoplasms 22Squamous Cell Carcinoma of Head and Neck 17Neoplasm Metastasis 17Recurrence 15Pancreatic Neoplasms 15Melanoma 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Ovarian Neoplasms 14Carcinoma, Hepatocellular 14Stomach Neoplasms 12Lymphoma, Non-Hodgkin 11Carcinoma, Renal Cell 11Rectal Neoplasms 10Lymphoma 10Colonic Neoplasms 10Brain Neoplasms 10Uterine Cervical Neoplasms 9Lymphoma, Follicular 9Kidney Neoplasms 9Esophageal Neoplasms 9Sarcoma 8Motor Activity 8

Interventions

merphos 1fludarabine phosphate 1Whole-Body Irradiation 1Thiotepa 1Tacrolimus 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methotrexate 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Biphenotypic, Acute × 30 days × Clear all
NCT02220985 2026-06-01

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

Fred Hutchinson Cancer Center

Phase 2 Completed
84 enrolled 22 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡